Concepedia

Elsa Lhériteau

EL

Statistics

Publications

8

Citations

1.5K

H-Index

8

Active since

2009

Affiliations

Inserm(Current)

Oniris

Nantes Université

Centre Hospitalier Universitaire de Nantes

Institut Pasteur

Elsa Lhériteau is an author at Inserm specializing in medicine, retinal degeneration, and immunology.

Publications per year

2009–2021

8

Publications

8

Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B

Amit Nathwani, Ulreke M. Reiss, Edward G. D. Tuddenham et al. · New England Journal of Medicine · 2014 · 1.3K citations · Full text

, , +17

Successful Gene Therapy in the RPGRIP1-deficient Dog: a Large Model of Cone–Rod Dystrophy

Elsa Lhériteau, Lolita Petit, Michel Weber et al. · Molecular Therapy · 2013 · 69 citations · Full text

, , +17

Restoration of Vision in the pde6β-deficient Dog, a Large Animal Model of Rod-cone Dystrophy

Lolita Petit, Elsa Lhériteau, Michel Weber et al. · Molecular Therapy · 2012 · 62 citations · Full text

, , +17

High neutralizing potency of swine glyco‐humanized polyclonal antibodies against SARS‐CoV‐2

Bernard Vanhove, Odile Duvaux, Juliette Rousse et al. · European Journal of Immunology · 2021 · 28 citations · Full text

, , +17

The RPGRIP1-deficient dog, a promising canine model for gene therapy.

Elsa Lhériteau, L. Libeau, Knut Stieger et al. · PubMed · 2009 · 24 citations · Full text

, , +17

1–5 of 8